199 related articles for article (PubMed ID: 33303890)
1. Generation of KS-58 as the first K-Ras(G12D)-inhibitory peptide presenting anti-cancer activity in vivo.
Sakamoto K; Masutani T; Hirokawa T
Sci Rep; 2020 Dec; 10(1):21671. PubMed ID: 33303890
[TBL] [Abstract][Full Text] [Related]
2. The K-Ras(G12D)-inhibitory peptide KS-58 suppresses growth of murine CT26 colorectal cancer cell-derived tumors.
Sakamoto K; Lin B; Nunomura K; Izawa T; Nakagawa S
Sci Rep; 2022 May; 12(1):8121. PubMed ID: 35581303
[TBL] [Abstract][Full Text] [Related]
3. Nanoformulation of the K-Ras(G12D)-inhibitory peptide KS-58 suppresses colorectal and pancreatic cancer-derived tumors.
Sakamoto K; Qi Y; Miyako E
Sci Rep; 2023 Jan; 13(1):518. PubMed ID: 36627374
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the structural requirements of K-Ras(G12D) selective inhibitory peptide KRpep-2d using alanine scans and cysteine bridging.
Niida A; Sasaki S; Yonemori K; Sameshima T; Yaguchi M; Asami T; Sakamoto K; Kamaura M
Bioorg Med Chem Lett; 2017 Jun; 27(12):2757-2761. PubMed ID: 28457754
[TBL] [Abstract][Full Text] [Related]
5. K-Ras(G12D)-selective inhibitory peptides generated by random peptide T7 phage display technology.
Sakamoto K; Kamada Y; Sameshima T; Yaguchi M; Niida A; Sasaki S; Miwa M; Ohkubo S; Sakamoto JI; Kamaura M; Cho N; Tani A
Biochem Biophys Res Commun; 2017 Mar; 484(3):605-611. PubMed ID: 28153726
[TBL] [Abstract][Full Text] [Related]
6. Metabolic profiling of gemcitabine- and paclitaxel-treated immortalized human pancreatic cell lines with K-RAS
Todaka A; Umehara R; Sasaki K; Serizawa M; Urakami K; Kusuhara M; Yamaguchi K; Yasui H
Biomed Res; 2017; 38(1):29-40. PubMed ID: 28239030
[TBL] [Abstract][Full Text] [Related]
7. Crystal Structure of a Human K-Ras G12D Mutant in Complex with GDP and the Cyclic Inhibitory Peptide KRpep-2d.
Sogabe S; Kamada Y; Miwa M; Niida A; Sameshima T; Kamaura M; Yonemori K; Sasaki S; Sakamoto JI; Sakamoto K
ACS Med Chem Lett; 2017 Jul; 8(7):732-736. PubMed ID: 28740607
[TBL] [Abstract][Full Text] [Related]
8. K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment.
Réjiba S; Wack S; Aprahamian M; Hajri A
Cancer Sci; 2007 Jul; 98(7):1128-36. PubMed ID: 17489984
[TBL] [Abstract][Full Text] [Related]
9. The role of K-ras gene mutation in TRAIL-induced apoptosis in pancreatic and lung cancer cell lines.
Sahu RP; Batra S; Kandala PK; Brown TL; Srivastava SK
Cancer Chemother Pharmacol; 2011 Feb; 67(2):481-7. PubMed ID: 20848283
[TBL] [Abstract][Full Text] [Related]
10. Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways.
Wang Z; Banerjee S; Ahmad A; Li Y; Azmi AS; Gunn JR; Kong D; Bao B; Ali S; Gao J; Mohammad RM; Miele L; Korc M; Sarkar FH
PLoS One; 2011; 6(6):e20537. PubMed ID: 21673986
[TBL] [Abstract][Full Text] [Related]
11. Rasfonin, a novel 2-pyrone derivative, induces ras-mutated Panc-1 pancreatic tumor cell death in nude mice.
Xiao Z; Li L; Li Y; Zhou W; Cheng J; Liu F; Zheng P; Zhang Y; Che Y
Cell Death Dis; 2014 May; 5(5):e1241. PubMed ID: 24853419
[TBL] [Abstract][Full Text] [Related]
12. Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants.
Khan I; Koide A; Zuberi M; Ketavarapu G; Denbaum E; Teng KW; Rhett JM; Spencer-Smith R; Hobbs GA; Camp ER; Koide S; O'Bryan JP
Cell Rep; 2022 Feb; 38(6):110322. PubMed ID: 35139380
[TBL] [Abstract][Full Text] [Related]
13. Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells.
Bocci G; Fioravanti A; Orlandi P; Bernardini N; Collecchi P; Del Tacca M; Danesi R
Br J Cancer; 2005 Aug; 93(3):319-30. PubMed ID: 16052215
[TBL] [Abstract][Full Text] [Related]
14. Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma.
Mohammad RM; Li Y; Mohamed AN; Pettit GR; Adsay V; Vaitkevicius VK; Al-Katib AM; Sarkar FH
Pancreas; 1999 Nov; 19(4):353-61. PubMed ID: 10547195
[TBL] [Abstract][Full Text] [Related]
15. Recombinant expression of different mutant K-ras gene in pancreatic cancer Bxpc-3 cells and its effects on chemotherapy sensitivity.
Shao T; Zheng Y; Zhao B; Li T; Cheng K; Cai W
Sci China Life Sci; 2014 Oct; 57(10):1011-7. PubMed ID: 25216706
[TBL] [Abstract][Full Text] [Related]
16. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
[TBL] [Abstract][Full Text] [Related]
17. Constitutive K-RasG12D activation of ERK2 specifically regulates 3D invasion of human pancreatic cancer cells via MMP-1.
Botta GP; Reginato MJ; Reichert M; Rustgi AK; Lelkes PI
Mol Cancer Res; 2012 Feb; 10(2):183-96. PubMed ID: 22160930
[TBL] [Abstract][Full Text] [Related]
18. Response to first-line chemotherapy in patients with non-small-cell lung cancer according to epidermal growth factor receptor and K-RAS mutation status.
Dong X; Zhao X; Hao Y; Wei Y; Yin Q; Du J
Clin Lung Cancer; 2013 Nov; 14(6):680-7. PubMed ID: 23910066
[TBL] [Abstract][Full Text] [Related]
19. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.
Nagathihalli NS; Castellanos JA; Shi C; Beesetty Y; Reyzer ML; Caprioli R; Chen X; Walsh AJ; Skala MC; Moses HL; Merchant NB
Gastroenterology; 2015 Dec; 149(7):1932-1943.e9. PubMed ID: 26255562
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of human pancreatic cancer cell lines by anti-sense oligonucleotides specific to mutated K-ras genes.
Kita K; Saito S; Morioka CY; Watanabe A
Int J Cancer; 1999 Feb; 80(4):553-8. PubMed ID: 9935156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]